Cargando…

Lifestyle changes and kidney function: A 10‐year follow‐up study in patients with manifest cardiovascular disease

BACKGROUND: Patients with cardiovascular disease (CVD) are at higher risk of kidney function decline. The current study aimed to examine the association of lifestyle changes with kidney function decline in patients with manifest CVD. METHODS: A total of 2260 patients from the Utrecht Cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Østergaard, Helena Bleken, Demirhan, Imre, Westerink, Jan, Verhaar, Marianne C., Asselbergs, Folkert W., de Borst, Gert J., Kappelle, L. Jaap, Visseren, Frank L. J., van der Leeuw, Joep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540114/ https://www.ncbi.nlm.nih.gov/pubmed/35579056 http://dx.doi.org/10.1111/eci.13814

Ejemplares similares

End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
por: de Vries, Tamar Irene, et al.
Publicado: (2021)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE study
por: Østergaard, Helena Bleken, et al.
Publicado: (2022)

External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease
por: Smidt, Lisanne C. A., et al.
Publicado: (2021)

Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2020)

Cohort profile: the Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study–an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands
por: Castelijns, Maria C, et al.
Publicado: (2023)

Screen-detected abnormal ankle brachial index: A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease
por: Jagt, Vivianne L., et al.
Publicado: (2022)

Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus
por: de Vries, T. I., et al.
Publicado: (2018)

Applicability of Transcutaneous Oxygen Tension Measurement in the Assessment of Chronic Limb-Threatening Ischemia
por: Leenstra, Bernard, et al.
Publicado: (2019)

The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study
por: van’t Klooster, Cilie C, et al.
Publicado: (2019)

Chronic kidney disease and atrial fibrillation: A dangerous combination
por: Ocak, Gurbey, et al.
Publicado: (2022)

Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease
por: van de Woestijne, Anton P., et al.
Publicado: (2014)

Physical Activity and Characteristics of the Carotid Artery Wall in High‐Risk Patients—The SMART (Second Manifestations of Arterial Disease) Study
por: Boss, H. Myrthe, et al.
Publicado: (2017)

Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study
por: Kanhai, Danny A, et al.
Publicado: (2014)

Misinterpretation of ischaemic infarct location in relationship to the cerebrovascular territories
por: Hartkamp, Nolan S, et al.
Publicado: (2016)

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
por: Sharif, Shahnam, et al.
Publicado: (2021)

Pharmacological and non-pharmacological interventions to influence adipose tissue function
por: Westerink, Jan, et al.
Publicado: (2011)

The effect of computerized decision support systems on cardiovascular risk factors: a systematic review and meta-analysis
por: Groenhof, T. Katrien J., et al.
Publicado: (2019)

Routinely measured hematological parameters and prediction of recurrent vascular events in patients with clinically manifest vascular disease
por: Kofink, Daniel, et al.
Publicado: (2018)

Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART‐REACH Model
por: Kaasenbrood, Lotte, et al.
Publicado: (2018)

Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia
por: Wisman, Peter Paul, et al.
Publicado: (2015)

A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia
por: Gremmels, Hendrik, et al.
Publicado: (2019)

Indoxyl Sulfate Stimulates Angiogenesis by Regulating Reactive Oxygen Species Production via CYP1B1
por: Pei, Jiayi, et al.
Publicado: (2019)

Preventing Deep Vein Thrombosis After Stroke: Strategies and Recommendations
por: Kappelle, L. Jaap
Publicado: (2011)

Arterial stiffness as a risk factor for cardiovascular events and all‐cause mortality in people with Type 2 diabetes
por: Sharif, S., et al.
Publicado: (2019)

Cell Therapy for Chronic Limb‐Threatening Ischemia: Current Evidence and Future Directions
por: Teraa, Martin, et al.
Publicado: (2018)

Conditioned media from (pre)adipocytes stimulate fibrinogen and PAI-1 production by HepG2 hepatoma cells
por: Faber, D R, et al.
Publicado: (2012)

The ClearSight System for Postoperative Arterial Blood Pressure Monitoring After Carotid Endarterectomy: A Validation Study
por: Fassaert, Leonie M M, et al.
Publicado: (2021)

Intervention versus standard medical treatment in patients with symptomatic occlusion of the internal carotid artery: a randomised oxygen-15 PET study
por: Persoon, Suzanne, et al.
Publicado: (2013)

One Heartbeat Away from a Prediction Model for Cardiovascular Diseases in Patients with Chronic Kidney Disease: A Systematic Review
por: Smit, Leanne C.M., et al.
Publicado: (2023)

The Global Limb Anatomic Staging System (GLASS) for CLTI: Improving Inter-Observer Agreement
por: Wijnand, Joep G. J., et al.
Publicado: (2021)

Platelet aggregation inhibitor prescription for newly diagnosed peripheral arterial disease in the Netherlands: a cohort study
por: Brand, Aarent RT, et al.
Publicado: (2021)

Ipsilateral foetal-type posterior cerebral artery is associated with cognitive decline after carotid revascularisation
por: Altinbas, Aysun, et al.
Publicado: (2014)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Modifiable risk factors in adults with and without prior cardiovascular disease: findings from the Indonesian National Basic Health Research
por: Arsyad, Dian Sidik, et al.
Publicado: (2022)

Added value of cardiovascular calcifications for prediction of recurrent cardiovascular events and cardiovascular interventions in patients with established cardiovascular disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2021)

Functional outcome of arterial thoracic outlet syndrome treatment
por: de Kleijn, Robert J. C. M. F., et al.
Publicado: (2023)

Separating the effects of 24-hour urinary chloride and sodium excretion on blood pressure and risk of hypertension: Results from PREVEND
por: van der Leeuw, Joep, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uuqc71vjl9jc230ip7c3qqp836